Mohammad Hirmand, EVP and Chief Medical Officer at Turning Point Therapeutics, Inc. (TPTX), sold 19,047 shares at $120.42 ($2.3M) on 2021-01-04, disclosed to the SEC on 2021-01-05.
Open-market sale of $2.3M TPTX by EVP and Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $120.42 | 8,747 | $1.1M | 45.9% |
| 2 | $120.42 | 8,747 | $1.1M | 45.9% |
| 3 | $122.44 | 300 | $37K | 1.6% |
| 4 | $120.00 | 1,253 | $150K | 6.6% |
| Total | $120.42 avg | 19,047 | $2.3M | 100% |
| Filing → |
| MDVN | SELL | 2015-12-04 | $47K | — | Filing → |
| MDVN | SELL | 2015-11-12 | $10K | — | Filing → |